Consumer protection bill
This article was originally published in The Rose Sheet
Executive SummaryHR 2621 moves to the Senate after passing lower chamber June 11 by voice vote. Measure would amend the Federal Anti-Tampering Act by making it a crime to "knowingly stamp, print, place or insert any writing in or on any consumer product...prior to its sale" without the consent of the product's manufacturer, distributor or retailer. Consumer Product Protection Act of 2002, introduced last July by Rep. Melissa Hart (D-Penn.) and amended May 8, was spurred by recent product tampering cases primarily in the food industry. Speaking about the bill, Rep. Tammy Baldwin (D-Wisc.) notes "it has become clear that law enforcement officials lack the authority to prosecute these crimes under state or federal law." The Cosmetic, Toiletry & Fragrance Association supports the bill...
You may also be interested in...
Rather than blame employees for ignoring 397 product complaints, Teligent should have fixed complaint handling system, US FDA warning letter says.
Device Week, 12 December 2019 – Global Insulin Pump Market Will Face Fierce Rivalry Among Major Players In 2020
In this edition of Device Week, Medtech Insight's deputy editor Reed Miller chats with managing editor Marion Webb about her latest in-depth Market Intel story, the first part of a two-part series focusing on the competitive landscape of the global insulin pump market.
COMPASS is testing a synthetic form of psilocybin, the active “magic mushroom” ingredient, in long-term depression patients, and thinks the capsule can be approved by 2025, its CEO tells Scrip.